Phillip Gomez, Siga Technologies CEO (via website)
July 28, 2023 01:55 PM EDT
Pharma
Manufacturing

US gov­ern­ment to ac­quire $138M worth of Tpoxx dos­es

Tyler Patchen

News Reporter

Siga Tech­nolo­gies said Thurs­day that the US has or­dered $113 mil­lion of the com­pa­ny’s oral Tpoxx treat­ment cours­es and $25 mil­lion of the in­tra­venous ver­sion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times